Advertisement

Intensive Care Medicine

, Volume 39, Issue 4, pp 747–753 | Cite as

Vasopressin and copeptin levels in children with sepsis and septic shock

  • Jan Hau LeeEmail author
  • Yoke Hwee Chan
  • Oi Fah Lai
  • Janil Puthucheary
Pediatric Original

Abstract

Purpose

Levels of vasopressin and its precursor copeptin in pediatric sepsis and septic shock are not well defined. The main aim of this study is to compare the serum levels of vasopressin and copeptin in children with septic shock or sepsis and in healthy children. We hypothesized that vasopressin and copeptin levels are elevated in early and late stages of pediatric septic shock.

Methods

Three groups were included: healthy children, children with clinical diagnosis of sepsis, and children admitted to the pediatric intensive care unit (PICU) with diagnosis of sepsis shock. Blood samples were drawn from children in all groups within 24 h of admission. For the septic shock group, additional samples at 24-h intervals were drawn up to 120 h after PICU admission. We used competitive immunoassays to determine vasopressin and copeptin levels.

Results

There were 70 children in the control group, 53 children in the sepsis group, and 13 in the septic shock group. At baseline, there was a difference in median vasopressin levels [60.9 (Interquartile range: 32.3, 138.0) vs. 141.1 (45.2, 542) vs. 326 (55.6, 399) pg/mL, p < 0.05], but there was no difference in copeptin levels [1.2 (0.8, 1.8) vs. 1.5 (1.0, 2.2) vs. 0.9 (0.8, 1.2) ng/mL, p = 0.14] between the three groups. There was no difference in vasopressin and copeptin levels in early and late stages of pediatric septic shock.

Conclusions

Baseline vasopressin levels were different between the three groups. In pediatric septic shock, vasopressin and copeptin levels are not robust markers for severity and clinical outcomes.

Keywords

Vasopressin Copeptin Sepsis Septic shock Pediatrics Child 

Notes

Acknowledgments

This study was funded by the National Research Medical Council, Singapore under the New Investigator Grant award. The authors would like to thank Ms. Liu Juan, Ms. Yu BuDuo, Ms. Ng Poh Ling and Ms. Diana Teo from the hospital’s research center for their administrative assistance and recruitment of patients; and Ms. Cecilia Chandra and Dianne Bautista for their kind statistical advice. The authors also appreciate the support of SingHealth/Duke-NUS Academic Medicine Research Institute, Singapore and medical editing assistance of Taara Madhavan (Associate in Clinical Sciences, Duke-NUS Graduate Medical School, Singapore).

References

  1. 1.
    Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167:695–701PubMedCrossRefGoogle Scholar
  2. 2.
    Odetola FO, Gebremariam A, Freed GL (2007) Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 119:487–494PubMedCrossRefGoogle Scholar
  3. 3.
    Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688PubMedCrossRefGoogle Scholar
  4. 4.
    Jaramillo-Bustamante JC, Marin-Agudelo A, Fernandez-Laverde M, Bareno-Silva J (2012) Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study. Pediatr Crit Care Med 13(5):501–508Google Scholar
  5. 5.
    Kissoon N, Orr RA, Carcillo JA (2010) Updated American College of Critical Care Medicine—pediatric advanced life support guidelines for management of pediatric and neonatal septic shock: relevance to the emergency care clinician. Pediatr Emerg Care 26:867–869PubMedCrossRefGoogle Scholar
  6. 6.
    Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E (2008) Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 34:511–517PubMedCrossRefGoogle Scholar
  7. 7.
    Choong K, Kissoon N (2008) Vasopressin in pediatric shock and cardiac arrest. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 9:372–379CrossRefGoogle Scholar
  8. 8.
    Barrett LK, Singer M, Clapp LH (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33–40PubMedCrossRefGoogle Scholar
  9. 9.
    Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752–1758PubMedCrossRefGoogle Scholar
  10. 10.
    Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, Paillard M, Raphael JC, Gajdos P, Annane D (2002) Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 30:497–500PubMedCrossRefGoogle Scholar
  11. 11.
    Lodha R, Vivekanandhan S, Sarthi M, Kabra SK (2006) Serial circulating vasopressin levels in children with septic shock. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 7:220–224CrossRefGoogle Scholar
  12. 12.
    Leclerc F, Walter-Nicolet E, Leteurtre S, Noizet O, Sadik A, Cremer R, Fourier C (2003) Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med 29:1339–1344PubMedCrossRefGoogle Scholar
  13. 13.
    Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500–2504PubMedCrossRefGoogle Scholar
  14. 14.
    Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112–119PubMedCrossRefGoogle Scholar
  15. 15.
    Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 6:2–8CrossRefGoogle Scholar
  16. 16.
    Peters MJ, Tasker RC, Kiff KM, Yates R, Hatch DJ (1998) Acute hypoxemic respiratory failure in children: case mix and the utility of respiratory severity indices. Intensive Care Med 24:699–705PubMedCrossRefGoogle Scholar
  17. 17.
    Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, Charpie JR, Hirsch JC (2010) Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 11:234–238PubMedCrossRefGoogle Scholar
  18. 18.
    Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192–197PubMedCrossRefGoogle Scholar
  19. 19.
    Russell JA (2007) Vasopressin in septic shock. Crit Care Med 35:S609–S615PubMedCrossRefGoogle Scholar
  20. 20.
    Repaske DR, Medlej R, Gultekin EK, Krishnamani MR, Halaby G, Findling JW, Phillips JA 3rd (1997) Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1–>Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. J Clin Endocrinol Metab 82:51–56PubMedCrossRefGoogle Scholar
  21. 21.
    Choi SJJH, WIllis BL, Newth CJ, Bart BD, Wetzel RC (2003) Vasopressin deficiency in pediatric septic shock. Pediatr Crit Care Med 4:141Google Scholar
  22. 22.
    Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D’Alessandro D, Oz MC, Oliver JA (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122–1125PubMedCrossRefGoogle Scholar
  23. 23.
    Morgenthaler NG, Struck J, Jochberger S, Dunser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol metab TEM 19:43–49CrossRefGoogle Scholar
  24. 24.
    Schlapbach LJ, Frey S, Bigler S, Manh-Nhi C, Aebi C, Nelle M, Nuoffer JM (2011) Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia. BMC Pediatr 11:38PubMedCrossRefGoogle Scholar
  25. 25.
    Michels M, Djamiatun K, Faradz SM, Koenders MM, de Mast Q, van der Ven AJ (2011) High plasma mid-regional pro-adrenomedullin levels in children with severe dengue virus infections. J Clin Virol Off Pub Pan Am Soc Clin Virol 50:8–12CrossRefGoogle Scholar
  26. 26.
    Jochberger S, Mayr VD, Luckner G, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder W, Friesenecker B, Mayr AJ, Dunser MW (2006) Serum vasopressin concentrations in critically ill patients. Crit Care Med 34:293–299PubMedCrossRefGoogle Scholar
  27. 27.
    Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28:219–226PubMedCrossRefGoogle Scholar
  28. 28.
    Jochberger S, Dorler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dunser MW (2009) The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 37:476–482PubMedCrossRefGoogle Scholar
  29. 29.
    Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, Litalien C, Menon K, McNamara P, Ward RE (2009) Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 180:632–639PubMedCrossRefGoogle Scholar
  30. 30.
    Jochberger S, Morgenthaler NG, Mayr VD, Luckner G, Wenzel V, Ulmer H, Schwarz S, Hasibeder WR, Friesenecker BE, Dunser MW (2006) Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 91:4381–4386PubMedCrossRefGoogle Scholar
  31. 31.
    Jochberger S, Zitt M, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dunser MW (2009) Postoperative vasopressin and copeptin levels in noncardiac surgery patients: a prospective controlled trial. Shock 31:132–138PubMedCrossRefGoogle Scholar
  32. 32.
    Standage SW, Wong HR (2011) Biomarkers for pediatric sepsis and septic shock. Exp Rev Anti infect Ther 9:71–79CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2013

Authors and Affiliations

  • Jan Hau Lee
    • 1
    • 2
    Email author
  • Yoke Hwee Chan
    • 1
    • 2
  • Oi Fah Lai
    • 3
  • Janil Puthucheary
    • 1
    • 2
  1. 1.Children’s Intensive Care Unit, Department of Paediatric SubspecialtiesKK Women’s and Children’s HospitalSingaporeSingapore
  2. 2.Duke-NUS Graduate School of MedicineSingaporeSingapore
  3. 3.Department of Clinical ResearchSingapore General HospitalSingaporeSingapore

Personalised recommendations